Mark Diamond has been the CEO of Antisense Therapeutics Limited (ASX:ANP) since 2001. This analysis aims first to contrast CEO compensation with other companies that have similar market capitalization. Next,
Read More...

Every investor in Antisense Therapeutics Limited (ASX:ANP) should be aware of the most powerful shareholder groups. Generally speaking, as a company grows, institutions will increase their ownership. Conversely, insiders often Read More...